GSA CAPITAL PARTNERS LLP - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 68 filers reported holding CASI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$122,000
+212.8%
78,572
+377.9%
0.01%
+133.3%
Q1 2021$39,000
-74.7%
16,442
-68.5%
0.01%
-76.0%
Q4 2020$154,000
+396.8%
52,146
+157.4%
0.02%
+400.0%
Q3 2020$31,00020,2600.01%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 896,137$4,185,0002.27%
Wellington Shields Capital Management, LLC 888,333$4,149,0000.67%
Manatuck Hill Partners, LLC 15,090$70,0000.03%
IHT Wealth Management, LLC 10,725$50,0000.01%
ALPS ADVISORS INC 153,234$716,0000.01%
Perceptive Advisors 43,682$204,0000.01%
ROYCE & ASSOCIATES LP 78,742$368,0000.00%
Tower Research Capital LLC (TRC) 5,974$28,0000.00%
MEEDER ASSET MANAGEMENT INC 5,863$28,0000.00%
METROPOLITAN LIFE INSURANCE CO/NY 18,585$86,7920.00%
View complete list of CASI PHARMACEUTICALS INC shareholders